Renal A2B Adenosine Receptors during ischemic preconditioning
Renal A2B Adenosine Receptors during ischemic preconditioning
批准号:
62727362
负责人:
Dr. Almut Grenz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2012-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Extracellular nucleotides liberated at inflammatory/hypoxic tissue sites are metabolized to adenosine by surface-expressed ecto-nucleotidases and activate adenosine receptors (ARs). Several studies implicate an important role of extracellular adenosine in tissue protection during conditions of limited oxygen availability. Here, we present preliminary data showing ecto-nucleotidase-dependent adenosine generation and signalling – particularly through the A2BAR – in renal protection during ischemic preconditioning (IP). Therefore, three specific aims are proposed to further identify and functionally characterize mechanisms of A2BAR-dependent tissue protection of the kidneys during ischemia. As first step, we will define the tissue-specific localization of the renal A2BAR and its expressional responses to ischemia and IP in vivo. Based on these studies, we will utilize in vitro models of renal hypoxia and preconditioning to understand A2BAR-dependent mechanisms of tissue protection during preconditioning. Finally, we will define strategies to target the A2BAR during renal ischemia in vivo. These experiments will facilitate significant progress on several fronts, including a more basic understanding of innate mechanisms of renal adaptation to ischemia/hypoxia. In addition, novel pharmacological approaches to diseases precipitated by renal ischemia/hypoxia would be made, a medical problem contributing to morbidity and mortality of critically ill patients from different fields of medicine and surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
激活腺苷A2B受体下调HIF-1α抑制Tregs耗竭参与特发性炎性肌病发病的作用机制研究
-
批准号:2025JJ60790
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:周月圆
-
依托单位:
腺苷 A2B 受体抑制剂通过下调CD73/腺苷信号系统治疗放射性皮肤损伤的分子机制研究
-
批准号:2022JJ70021
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:罗凌嵘
-
依托单位:
难治性勃起功能障碍的关键机制:腺苷A2B受体介导的AMPK-自噬信号通路异常
-
批准号:82071639
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2020
-
负责人:袁久洪
-
依托单位:
线粒体自噬在腺苷A2B受体活化诱导心肌再灌注保护中的作用及机制研究
-
批准号:81700324
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:徐菁蔓
-
依托单位:
腺苷A2B受体信号通路促肾纤维化机制:对巨噬细胞募集和极化的影响
-
批准号:81570625
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:张卫茹
-
依托单位:
腺苷A2B受体调控脾来源单核/巨噬细胞极化减轻心肌缺血再灌注损伤的机制研究
-
批准号:81400213
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:田轶魁
-
依托单位:
腺苷A2B受体在促进乳腺肿瘤发生和转移的作用及机制研究
-
批准号:81402316
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:孙颖
-
依托单位:
腺苷受体A2b对少突胶质前体细胞发育和存活的调控及机制
-
批准号:31360240
-
项目类别:地区科学基金项目
-
资助金额:58.0万元
-
批准年份:2013
-
负责人:马全瑞
-
依托单位:
氧化苦参碱对A2B介导高糖高脂毒性下血管内皮细胞保护作用及机制研究
-
批准号:81360136
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2013
-
负责人:高云
-
依托单位:
腺苷受体A2B作为多发性硬化症治疗靶点及机制研究
-
批准号:31171348
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:杜昌升
-
依托单位: